+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
298708-79-9,MFCD30729326
Catalog No.:AA01E6CE

298708-79-9 | BAY 41-4109 Racemate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$46.00   $32.00
- +
5mg
98%
in stock  
$113.00   $79.00
- +
10mg
98%
in stock  
$218.00   $153.00
- +
25mg
98%
in stock  
$529.00   $370.00
- +
50mg
98%
in stock  
$722.00   $505.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01E6CE
Chemical Name:
BAY 41-4109 Racemate
CAS Number:
298708-79-9
Molecular Formula:
C18H13ClF3N3O2
Molecular Weight:
395.7629
MDL Number:
MFCD30729326
SMILES:
COC(=O)C1=C(C)N=C(NC1c1ccc(cc1Cl)F)c1ncc(cc1F)F
Properties
Computed Properties
 
Complexity:
645  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.1  

Literature

Title: Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Journal: Antimicrobial agents and chemotherapy 20131101

Title: Weber O, et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 2002 May;54(2):69-78.

Title: Stray SJ, et al. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly. J Mol Recognit. 2006 Nov-Dec;19(6):542-8.

Title: Wu GY, et al. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. J Chemother. 2008 Aug;20(4):458-67.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 298708-79-9
Building Blocks
More >
Tags:298708-79-9 Molecular Formula|298708-79-9 MDL|298708-79-9 SMILES|298708-79-9 BAY 41-4109 Racemate
Catalog No.: AA01E6CE
298708-79-9,MFCD30729326
298708-79-9 | BAY 41-4109 Racemate
Pack Size： 1mg
Purity： 98%
in stock
$46.00 $32.00
Pack Size： 5mg
Purity： 98%
in stock
$113.00 $79.00
Pack Size： 10mg
Purity： 98%
in stock
$218.00 $153.00
Pack Size： 25mg
Purity： 98%
in stock
$529.00 $370.00
Pack Size： 50mg
Purity： 98%
in stock
$722.00 $505.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01E6CE
Chemical Name: BAY 41-4109 Racemate
CAS Number: 298708-79-9
Molecular Formula: C18H13ClF3N3O2
Molecular Weight: 395.7629
MDL Number: MFCD30729326
SMILES: COC(=O)C1=C(C)N=C(NC1c1ccc(cc1Cl)F)c1ncc(cc1F)F
Properties
Complexity: 645  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 27  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.1  
Literature fold

Title: Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Journal: Antimicrobial agents and chemotherapy20131101

Title: Weber O, et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 2002 May;54(2):69-78.

Title: Stray SJ, et al. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly. J Mol Recognit. 2006 Nov-Dec;19(6):542-8.

Title: Wu GY, et al. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. J Chemother. 2008 Aug;20(4):458-67.

Related Products of of 298708-79-9
Building Blocks More >
1629166-02-4
1629166-02-4
SBC-110736
AA01E6RG | MFCD30541539
5689-39-4
5689-39-4
1-(1-methyl-1H-indol-3-yl)propan-2-amine hydrochloride
AA01E6ZM | MFCD31665981
1226033-55-1
1226033-55-1
4-chloro-n-(3-piperidinylmethyl)aniline
AA01E77E | MFCD16313464
2023240-30-2
2023240-30-2
1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-4-(methoxymethyl)piperidine-4-carboxylic acid
AA01E79K | MFCD30730410
2126160-32-3
2126160-32-3
2-(pyrrolidin-1-yl)-6-(pyrrolidin-3-yl)pyrimidin-4-ol dihydrochloride
AA01E7D2 | MFCD30751535
2126161-06-4
2126161-06-4
(3-bromo-1-methyl-1H-pyrazol-4-yl)methanamine hydrochloride
AA01E7G6 | MFCD30751426
1291445-04-9
1291445-04-9
4-(oxan-4-yloxy)butanoic acid
AA01E7JD | MFCD14614834
2094139-05-4
2094139-05-4
4-bromo-3-(2-cyclohexylethoxy)aniline hydrochloride
AA01E7MK | MFCD30751325
2095410-99-2
2095410-99-2
2-{[4-(trifluoromethyl)phenyl]methoxy}pyridine-3-carboxylic acid
AA01E7P7 | MFCD30730488
1271478-86-4
1271478-86-4
4-{[2-(4-methyl-1,3-thiazol-2-yl)ethyl]amino}benzoic acid
AA01E7U6 | MFCD19123214
Submit
© 2017 AA BLOCKS, INC. All rights reserved.